Beijing Wantai Biological Hits Day High with 4.96% Surge in Stock Price

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. has shown significant activity today, with the stock rising by 4.96% as of June 1, 2026. The stock reached an intraday high of CNY 36.50, marking a notable point in its trading session. In terms of performance metrics, the company has outperformed the China Shanghai Composite index, which declined by 0.27% on the same day. Over the past week, Beijing Wantai has increased by 2.88%, contrasting with the index's 2.28% drop. However, the stock has faced challenges over longer periods, with a 1-month decline of 7.43% and a substantial 47.5% decrease over the past year. Beijing Wantai operates within the Pharmaceuticals & Biotechnology sector and holds a market capitalization of CNY 50,027 million. Despite its recent gains, the company has experienced significant declines over the past three and five years, with losses of 61.43% and 84.18%, respectively. The stock currently reflects a price-to-book ratio of 4.23, indicating its valuation relative to its equity.